The CRISPR-Chip will change the QC in Genome Editing - Interview with CSO, Kiana Aran


Read interview with CSO, Kiana Aran from Cardea Bio - US-based partner to COBO Technologies

The CRISPR-Chip can optimise your Cas, diagnose COVID19 and change our world.

Interview with Kiana Aran, CSO, Cardea Bio.

Kiana talks about the first products in quality control for CRISPR gene-editing, and how she expects the CRISPR-Chip soon to revolutionise biology.

Read full interview here.